The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354
Novel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Neutrophil kinetics in health and disease
Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., & Chilvers, E. R. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.006 · Cited by 1,242
De Filippo, K., Dudeck, A., Hasenberg, M., Nye, E., van Rooijen, N., Hartmann, K., Gunzer, M., Roers, A., & Hogg, N. (2013) · Blood · doi:10.1182/blood-2013-02-486217 · Cited by 880
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & McGarry Houghton, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 707
Marasco, W. A., Phan, S. H., Krutzsch, H., Showell, H. J., Feltner, D. E., Nairn, R., Becker, E. L., & Ward, P. A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91029-x · Cited by 521
Diamond, M. S., & Springer, T. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.2.545 · Cited by 505
Origin of the U87MG glioma cell line: Good news and bad news
Allen, M., Bjerke, M., Edlund, H., Nelander, S., & Westermark, B. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6853 · Cited by 466
Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells
Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H. A., Kohno, K., & Kuwano, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28220 · Cited by 454
Partida-Sánchez, S., Cockayne, D. A., Monard, S., Jacobson, E. L., Oppenheimer, N., Garvy, B., Kusser, K., Goodrich, S., Howard, M., Harmsen, A., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1209 · Cited by 450
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment
Gu, L., & Mooney, D. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.3 · Cited by 407
Keshari, R. S., Jyoti, A., Dubey, M., Kothari, N., Kohli, M., Bogra, J., Barthwal, M. K., & Dikshit, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048111 · Cited by 389
Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery
Mo, R., & Gu, Z. (2016) · Materials Today · doi:10.1016/j.mattod.2015.11.025 · Cited by 381
Self-citationScale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
Park, J. K., Hodges, T., Arko, L., Shen, M., Dello Iacono, D., McNabb, A., Olsen Bailey, N., Kreisl, T. N., Iwamoto, F. M., Sul, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0582 · Cited by 359
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., & Fridlender, Z. G. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1476-9 · Cited by 356
Lidar, Z., Mardor, Y., Jonas, T., Pfeffer, R., Faibel, M., Nass, D., Hadani, M., & Ram, Z. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.100.3.0472 · Cited by 342
Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559457 · Cited by 323
Mouse bone marrow contains large numbers of functionally competent neutrophils
Boxio, R., Bossenmeyer-Pourié, C., Steinckwich, N., Dournon, C., & Nüße, O. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703340 · Cited by 307
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 295
Brown, R. C., Morris, A. P., & O'Neil, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.083 · Cited by 291
The Pathobiology of Glioma Tumors
Gladson, C. L., Prayson, R. A., & Liu, W. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102109 · Cited by 254
Li, G., Simon, M. J., Cancel, L. M., Shi, Z.-D., Ji, X., Tarbell, J. M., Morrison, B., & Fu, B. M. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-010-0023-5 · Cited by 231
Sequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration
Ju, C., Mo, R., Xue, J., Zhang, L., Zhao, Z., Xue, L., Ping, Q., & Zhang, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311227 · Cited by 229
Self-citationNeutrophil infiltration into human gliomas
Fossati, G., Ricevuti, G., Edwards, S. W., Walker, C., Dalton, A., & Rossi, M. L. (1999) · Acta Neuropathologica · doi:10.1007/s004010051093 · Cited by 227
Hol, J., Wilhelmsen, L., & Haraldsen, G. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809532 · Cited by 206
PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP
Heit, B., Liu, L., Colarusso, P., Puri, K. D., & Kubes, P. (2008) · Journal of Cell Science · doi:10.1242/jcs.020412 · Cited by 156
Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
Salmaggi, A., Eoli, M., Frigerio, S., Silvani, A., Gelati, M., Corsini, E., Broggi, G., & Boiardi, A. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1023367223575 · Cited by 149
Nabors, B., Suswam, E. A., Huang, Y., Yang, X., Johnson, M. J., & King, P. H. (2003) · PubMed · Cited by 139
Recruitment of Neutrophils across the Blood–Brain Barrier: The Role of E- and P-selectins
Bernardes-Silva, M., Anthony, D. C., Issekutz, A. C., & Perry, V. H. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00009 · Cited by 116
Barriers to carrier mediated drug and gene delivery to brain tumors
Huynh, G. H., Deen, D. F., & Szoka, F. C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.053 · Cited by 111
Modulation of blood–brain barrier permeability by neutrophils: in vitro and in vivo studies
Joice, S. L., Mydeen, M. F. M., Couraud, P., Weksler, B. B., Romero, I. A., Fraser, P. A., & Easton, A. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.076 · Cited by 86
Induction of the chemokine IL-8/Kc by the articular cartilage: possible influence on osteoarthritis.
Chauffier, K., Laiguillon, M.-C., Bougault, C., Gosset, M., Priam, S., Salvat, C., Mladenovic, Z., Nourissat, G., Jacques, C., Houard, X., et al. (2012) · Joint, bone, spine : revue du rhumatisme · doi:10.1016/j.jbspin.2011.12.013 · Cited by 71
Surface Modification of RGD-Liposomes for Selective Drug Delivery to Monocytes/Neutrophils in Brain
Qin, J., Chen, D., Hu, H., Cui, Q., Qiao, M., & Chen, B. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.1192 · Cited by 66
Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies
Mangraviti, A., Gullotti, D. M., Tyler, B., & Brem, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.031 · Cited by 66
Chemotherapy in the treatment of malignant gliomas
Stern, J. I., & Raizer, J. J. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.5.755 · Cited by 24
Neutrophil activation during transmigration in vivo and in vitro
Paulsson, J. M., Jacobson, S. H., & Lundahl, J. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.07.015 · Cited by 17
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“364 The camou fl aged delivery system maintained the physiological features, which could ef fi ciently traverse BBB and migrate to in fl ammatory sites such as tumor parenchyma.”
BackgroundStrategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Self-citationNanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
Metadata
- Authors
- Xue, J., Zhao, Z., Zhang, L., Xue, L., Shen, S., Wen, Y., Wei, Z., Wang, L., Kong, L., Sun, H., Ping, Q., Mo, R., & Zhang, C.
- Venue
- Nature Nanotechnology
- Published
- 2017-06-19
- Volume
- 12
- Issue
- 7
- Pages
- 692-700
- ISSN
- 1748-3387 (ISSN-L)
- 1748-3395
- OpenAlex
- W2626252985
- Cited by
- 959
- References
- 49
- FWCI
- 20.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.